Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1042/BCJ20210426 http://scihub22266oqcxt.onion/10.1042/BCJ20210426 34198320!8286811!34198320     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Biochem+J 2021 ; 478 (13): 2533-2535 Nephropedia Template TP {{tp|p=34198320|t=2021. Author s overview: identifying SARS-CoV-2 antiviral compounds |pdf=|usr=}}{{34198320}} gab.com Text Author s overview: identifying SARS-CoV-2 antiviral compounds JO: Biochem J http://www.kidney.de/pget.php?&tw=1&pmid=34198320 #FOAvip In response to the COVID-19 pandemic, we began a project in March 2020 to identify small molecule inhibitors of SARS-CoV-2 enzymes from a library of chemical compounds containing many established pharmaceuticals. Our hope was that inhibitors we found might slow the replication of the SARS-CoV-2 virus in cells and ultimately be useful in the treatment of COVID-19. The seven accompanying manuscripts describe the results of these chemical screens. This overview summarises the main highlights from these screens and discusses the implications of our results and how our results might be exploited in future. Twit Text FOAVip Author s overview: identifying SARS-CoV-2 antiviral compounds ????Biochem J http://www.kidney.de/pget.php?&tw=1&pmid=34198320 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34198320 #FOAvip English Wikipedia <ref>{{Cite pmid|34198320}}</ref> Author s overview: identifying SARS-CoV-2 antiviral compounds #MMPMID34198320 Diffley JFX Biochem J 2021[Jul]; 478 (13): 2533-2535 PMID34198320show ga In response to the COVID-19 pandemic, we began a project in March 2020 to identify small molecule inhibitors of SARS-CoV-2 enzymes from a library of chemical compounds containing many established pharmaceuticals. Our hope was that inhibitors we found might slow the replication of the SARS-CoV-2 virus in cells and ultimately be useful in the treatment of COVID-19. The seven accompanying manuscripts describe the results of these chemical screens. This overview summarises the main highlights from these screens and discusses the implications of our results and how our results might be exploited in future. |*Drug Evaluation, Preclinical[MESH] |Animals[MESH] |Antiviral Agents/*chemistry/*pharmacology[MESH] |Enzyme Assays[MESH] |Humans[MESH] |SARS-CoV-2/drug effects/*enzymology[MESH] |Small Molecule Libraries/chemistry/*pharmacology[MESH]Author s overview: identifying SARS-CoV-2 antiviral compounds (epmc).pdf DeepDyve Pubget Overpricing